Severe ocular surface and corneal damage an unseen public health burden.
Shu-I Yeh, MD, PhD
Advertisement
Articles by Shu-I Yeh, MD, PhD
Advertisement
Latest Updated Articles
Novel approaches to treating severe ocular surface and corneal damagePublished: July 10th 2023 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
3
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
4
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
5
.png "Optometry Times"){kind=logo}
